These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31158489)

  • 1. Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory study.
    Bernasconi C; Pelkonen O; Andersson TB; Strickland J; Wilk-Zasadna I; Asturiol D; Cole T; Liska R; Worth A; Müller-Vieira U; Richert L; Chesne C; Coecke S
    Toxicol In Vitro; 2019 Oct; 60():212-228. PubMed ID: 31158489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-laboratory evaluation of the response of primary human hepatocyte cultures to model CYP inducers - a European Centre for Validation of Alternative Methods (ECVAM) - funded pre-validation study.
    Richert L; Abadie C; Bonet A; Heyd B; Mantion G; Alexandre E; Bachellier P; Kingston S; Pattenden C; Illouz S; Dennison A; Hoffmann S; Coecke S
    Toxicol In Vitro; 2010 Feb; 24(1):335-45. PubMed ID: 19497361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays.
    Murayama N; Usui T; Slawny N; Chesné C; Yamazaki H
    Drug Metab Lett; 2015; 9(1):3-7. PubMed ID: 25600204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
    Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
    Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics.
    Choi JM; Oh SJ; Lee SY; Im JH; Oh JM; Ryu CS; Kwak HC; Lee JY; Kang KW; Kim SK
    Arch Pharm Res; 2015; 38(5):691-704. PubMed ID: 25336106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
    Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
    J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment-free High-throughput Liquid Chromatography-Multiple-Reaction Monitoring Quantification of Cytochrome P450 Proteins in Plated Human Hepatocytes Direct from 96-Well Plates Enables Routine Protein Induction Measurements.
    Savaryn JP; Liu N; Sun J; Ma J; Stresser DM; Jenkins G
    Drug Metab Dispos; 2020 Jul; 48(7):594-602. PubMed ID: 32350061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Screening Criteria Setting on Evaluation of Cytochrome P450 Induction Using HepaRG Cells with Multiplex Branched DNA Technologies in Early Drug Discovery.
    Ogasawara A; Torimoto N; Tsuda N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2016; 10(3):152-160. PubMed ID: 27550199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells.
    Sugiyama I; Murayama N; Kuroki A; Kota J; Iwano S; Yamazaki H; Hirota T
    Xenobiotica; 2016 Sep; 46(9):765-74. PubMed ID: 26711482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2.
    Bachmann F; Duthaler U; Meyer Zu Schwabedissen HE; Puchkov M; Huwyler J; Haschke M; Krähenbühl S
    Clin Pharmacol Ther; 2021 Jun; 109(6):1505-1516. PubMed ID: 33336382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction.
    Li AP; Maurel P; Gomez-Lechon MJ; Cheng LC; Jurima-Romet M
    Chem Biol Interact; 1997 Nov; 107(1-2):5-16. PubMed ID: 9402946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cytochrome P450 (1A2, 2B6, 2C9 and 3A4) induction in cryopreserved human hepatocytes cultured in 48-well plates using the cocktail strategy.
    Gerin B; Dell'Aiera S; Richert L; Smith S; Chanteux H
    Xenobiotica; 2013 Apr; 43(4):320-35. PubMed ID: 23153057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
    Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
    Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies.
    Garcia M; Rager J; Wang Q; Strab R; Hidalgo IJ; Owen A; Li J
    In Vitro Cell Dev Biol Anim; 2003; 39(7):283-7. PubMed ID: 14599235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the inducibility of CYP mRNA exposed to typical inducers in fresh and cryopreserved cynomolgus monkey hepatocytes.
    Koeda A; Iwao T; Nakanishi A; Mizuno S; Yamashita M; Sakai Y; Nakamura K; Matsunaga T
    Drug Metab Pharmacokinet; 2020 Jun; 35(3):304-312. PubMed ID: 32303457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Tissue Stem Cell-Derived Human Intestinal Organoids, a Physiologically Relevant Model to Evaluate Cytochrome P450 Induction in Gut.
    Stresser DM; Sun J; Wilson SS
    Drug Metab Dispos; 2021 Mar; 49(3):245-253. PubMed ID: 33355212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 23 lots of commercially available cryopreserved hepatocytes for induction assays of human cytochromes P450.
    Yajima K; Uno Y; Murayama N; Uehara S; Shimizu M; Nakamura C; Iwasaki K; Utoh M; Yamazaki H
    Drug Metab Dispos; 2014 May; 42(5):867-71. PubMed ID: 24553381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.